Dr. David Samadi from RoboticOncology voices concerns of COVID-19's impact on prostate cancer screenings July 8, 2020 A concerning fallout from the March COVID-19 shutdown has been the disastrous drop in cancer screenings. This worrisome discovery is according to a study in May by Epic Health Research Network. A review of data from 39 health systems from 190 hospitals in 23 states, found alarming statistics: prostate specific antigen (PSA) screenings for detecting prostate cancer fell by 60 percent.Read the full article here.Source: PR Newswire Prostate Cancer News
A concerning fallout from the March COVID-19 shutdown has been the disastrous drop in cancer screenings. This worrisome discovery is according to a study in May by Epic Health Research Network. A review of data from 39 health systems from 190 hospitals in 23 states, found alarming statistics: prostate specific antigen (PSA) screenings for detecting prostate cancer fell by 60 percent.Read the full article here.Source: PR Newswire
